Abstract:Purpose: Vitiligo is an acquired depigmentation skin disease, which affects an average of 1% of the world's population. The purpose of this study is to identify the key genes and pathways responsible for vitiligo and find new therapeutic targets. Methods: The datasets GSE65127, GSE53146, and GSE75819 were downloaded from the Gene Expression Omnibus (GEO) database. R language was used to identify the differentially expressed genes (DEGs) between lesional skin of vitiligo and non-lesional skin. Next, the key pathways were obtained by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The protein-protein interaction (PPI) networks were conducted by STRING database and Cytoscape software. Subsequently, module analysis was performed by Cytoscape. Among these results, the Wnt/beta-catenin pathway and melanogenesis pathway caught our attention. The expression level of beta-catenin, microphthalmia-associated transcription factor (IVIITF) and tyrosinase (TYR) was detected by immunofluorescence in vitiligo lesions and healthy skin. Moreover, zebrafish was treated with XAV-939, an inhibitor of the Wnt/beta-catenin pathway. After that, the area of melanin granules as a percentage of the head area was measured. The mRNA expression of beta-catenin, lymphoid-enhancing factor 1 (lef1), tyr and miff were detected by q-PCR (quantitative polymerase chain reaction) in zebrafish (Danio rerio). Results: A total of 2442 DEGs were identified, including 1068 upregulated and 1374 downregulated DEGs. The key pathways were identified by GO and KEGG analyses, such as "NOD-like receptor signaling pathway", "Wnt signaling pathway", "Melanogenesis", "mTOR signaling pathway", "PI3K-Akt signaling pathway", "Calcium signaling pathway" and "Rapt signaling pathway". The immunofluorescence results showed that the level of beta-catenin, MITE and TYR was significantly downregulated in vitiligo lesional skin. In zebrafish, the mean percentage area of melanin granules and the expression of beta-catenin, lef1, tyr and miff were decreased after treated with XAV-939. Conclusion: The present study identified key genes and signaling pathways associated with the pathophysiology of vitiligo. Among them, the Wnt/beta-catenin pathway played an essential role in pigmentation and could be a breakthrough point in vitiligo treatment.

Exosome-derived microRNAs: emerging players in vitiligo

MicroRNAs: Emerging Players in the Pathogenesis of Vitiligo

067 Serum-derived Exosomes Contribute to Abnormal Melanocyte Function in Patients with Active Vitiligo

164 Micro RNAs Enriched in Exosome Derived from Keratinocytes under Oxidative Stress Contributes to Melanocyte Loss in Vitiligo

Circulating Exosomal miR-493-3p Affects Melanocyte Survival and Function by Regulating Epidermal Dopamine Concentration in Segmental Vitiligo.

Exosomes Containing miR-1469 Regulate Natural Killer Cells by Targeting CD122 in Non-Segmental Vitiligo

Micro RNAs upregulated in Vitiligo skin play an important role in its aetiopathogenesis by altering TRP1 expression and keratinocyte-melanocytes cross-talk

Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment.

Exosomal Mirnas in Autoimmune Skin Diseases

Identification of Upregulating Genes, Transcription Factors, and miRNAs in Vitiligo. In silico Study

Identification of a Potentially Functional circRNA-miRNA-mRNA Regulatory Network in Melanocytes for Investigating Pathogenesis of Vitiligo

Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm

Transcriptome and Differential Methylation Integration Analysis Identified Important Differential Methylation Annotation Genes and Functional Epigenetic Modules Related to Vitiligo

LB1599 Novel microenvironmental defects revealed by large scale transcriptome sequencing of lesional and nonlesional skin of vitiligo patients

Comprehensive Analysis of Exosomal MicroRNAs Derived from UVB-Irradiated Keratinocytes as Potential Melanogenesis Regulators

Vitiligo: A focus on pathogenesis and its therapeutic implications

Exosomes: The emerging mechanisms and potential clinical applications in dermatology

The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response

Identification of the Role of Wnt/-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo

3D‐hUMSCs Exosomes Ameliorate Vitiligo by Simultaneously Potentiating Treg Cells‐Mediated Immunosuppression and Suppressing Oxidative Stress‐Induced Melanocyte Damage

Post-translational modification in the pathogenesis of vitiligo